Petti MC - Search Results

1

Spontaneous remission in adult patients with de novo myelodysplastic syndrome: a possible event.

Petti MC, Latagliata R, Breccia M, Alimena G, Spadea A, D'Andrea M, Mancini M, Aloe Spiriti MA, Mandelli F. Petti MC, et al. Haematologica. 2001 Dec;86(12):1277-80. Haematologica. 2001. PMID: 11726319

2

Latagliata R, Petti MC, Fenu S, Mancini M, Spiriti MA, Breccia M, Brunetti GA, Avvisati G, Lo Coco F, Mandelli F. Latagliata R, et al. Among authors: petti mc. Blood. 2002 Feb 1;99(3):822-4. doi: 10.1182/blood.v99.3.822. Blood. 2002. PMID: 11806982 Free article.

3

Acute myeloid leukemia secondary to a myelodysplastic syndrome with t(3;3) (q21;q26) in an HIV patient treated with chemotherapy and highly active antiretroviral therapy.

Breccia M, Gentile G, Martino P, Petti MC, Russo E, Mancini M, Alimena G. Breccia M, et al. Among authors: petti mc. Acta Haematol. 2004;111(3):160-2. doi: 10.1159/000076525. Acta Haematol. 2004. PMID: 15034238

4

Defective antibody-dependent and lectin-induced polymorphonuclear cytotoxicity in patients with myelodysplastic syndromes.

Fontana L, De Sanctis G, Bottari V, Petti MC, Mandelli F. Fontana L, et al. Among authors: petti mc. Haematologica. 1990 Jan-Feb;75(1):46-9. Haematologica. 1990. PMID: 2338286

5

Is aggressive chemotherapy the best choice for patients with acute nonlymphocytic leukemia after myelodysplastic syndromes?

Latagliata R, Spiriti MA, Avvisati G, De Gregoris C, Fazi P, Spadea A, Petti MC. Latagliata R, et al. Among authors: petti mc. Leuk Res. 1995 Mar;19(3):213-7. doi: 10.1016/0145-2126(94)00140-6. Leuk Res. 1995. PMID: 7700082

6

Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim report.

Aloe Spiriti MA, Petti MC, Latagliata R, Avvisati G, De Gregoris C, Proia S, Fazi P, Jaalouk G, Mancini M, Spadea A, et al. Aloe Spiriti MA, et al. Among authors: petti mc. Haematologica. 1993 Mar-Apr;78(2):123-6. Haematologica. 1993. PMID: 8349188

7

Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile?

Aloe Spiriti MA, Petti MC, Latagliata R, Avvisati G, De Gregoris C, Proia S, Fazi P, Jaalouk G, Mancini M, Spadea A, et al. Aloe Spiriti MA, et al. Among authors: petti mc. Leuk Lymphoma. 1993 Jan;9(1-2):79-83. doi: 10.3109/10428199309148507. Leuk Lymphoma. 1993. PMID: 8477205

8

Erythropoietin in myelodysplastic syndromes: durable response in a young patient.

Aloe Spiriti MA, Latagliata R, Petti MC. Aloe Spiriti MA, et al. Among authors: petti mc. Haematologica. 1996 Jul-Aug;81(4):381-2. Haematologica. 1996. PMID: 8870388 No abstract available.

9

Treatment of high-risk myelodysplastic syndromes with lymphoblastoid alpha interferon.

Petti MC, Latagliata R, Avvisati G, Spiriti MA, Montefusco E, Spadea A, Mandelli F. Petti MC, et al. Br J Haematol. 1996 Nov;95(2):364-7. doi: 10.1046/j.1365-2141.1996.d01-1911.x. Br J Haematol. 1996. PMID: 8904893

10

Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.

Mandelli F, Petti MC, Lo Coco F. Mandelli F, et al. Among authors: petti mc. Haematologica. 1998 Nov;83(11):1015-23. Haematologica. 1998. PMID: 9864924 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters